pI: 5.6259 |
Length (AA): 317 |
MW (Da): 36943 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 317 | 1jl5 (A) | 1076 | 1361 | 17.00 | 0.000000000022 | 1 | 1.13 | 0.23 |
1 | 313 | 1o6v (A) | 100 | 400 | 31.00 | 0 | 1 | 1.36 | -0.55 |
237 | 303 | 1fo1 (A) | 291 | 358 | 28.00 | 0.000073 | 0.97 | 0.7 | -1.6 |
7 | 314 | 3wpe (A) | 306 | 698 | 28.00 | 0.00056 | 1 | 1.07451 | 0.59 |
12 | 70 | 2ft3 (A) | 51 | 113 | 24.00 | 0.13 | 0.7 | 0.46772 | -0.42 |
26 | 309 | 1o6v (A) | 153 | 450 | 33.00 | 0 | 1 | 1.2888 | -0.71 |
83 | 222 | 4tzh (A) | 44 | 187 | 36.00 | 0.000000022 | 1 | 0.97654 | -1.23 |
121 | 230 | 2ell (A) | 31 | 135 | 42.00 | 0.0003 | 0.95 | 0.692903 | 0.41 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 30 hs, intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intraerythrocytic - 36 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_127611)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G19680 | leucine-rich repeat-containing protein |
Babesia bovis | BBOV_II003040 | protein phosphatase 1, regulatory (inhibitor) subunit 7, putative |
Brugia malayi | Bm1_27240 | hypothetical protein |
Brugia malayi | Bm1_46990 | Leucine Rich Repeat family protein |
Candida albicans | CaO19.8440 | regulator of protein phosphatase 1 |
Candida albicans | CaO19.820 | regulator of protein phosphatase 1 |
Caenorhabditis elegans | CELE_T09A5.9 | Protein T09A5.9 |
Caenorhabditis elegans | CELE_C06A8.6 | Protein C06A8.6 |
Cryptosporidium hominis | Chro.60097 | protein phosphatase-1 regulatory subunit 7 alpha2 |
Cryptosporidium parvum | cgd6_750 | protein phosphatase-1 regulatory subunit 7 alpha2 |
Dictyostelium discoideum | DDB_G0284039 | hypothetical protein |
Drosophila melanogaster | Dmel_CG5851 | CG5851 gene product from transcript CG5851-RA |
Echinococcus granulosus | EgrG_000429200 | protein phosphatase 1 regulatory subunit 7 |
Echinococcus granulosus | EgrG_000473800 | protein phosphatase 1 regulatory subunit 7 |
Echinococcus multilocularis | EmuJ_000473800 | protein phosphatase 1 regulatory subunit 7 |
Echinococcus multilocularis | EmuJ_000429200 | protein phosphatase 1 regulatory subunit 7 |
Homo sapiens | ENSG00000115685 | protein phosphatase 1, regulatory subunit 7 |
Leishmania braziliensis | LbrM.05.1200 | protein phosphatase type 1 regulator-like protein |
Leishmania donovani | LdBPK_051200.1 | protein phosphatase type 1 regulator-like protein |
Leishmania infantum | LinJ.05.1200 | protein phosphatase type 1 regulator-like protein |
Leishmania major | LmjF.05.1210 | protein phosphatase type 1 regulator-like protein |
Leishmania mexicana | LmxM.05.1210 | protein phosphatase type 1 regulator-like protein |
Loa Loa (eye worm) | LOAG_00522 | leucine Rich Repeat family protein |
Loa Loa (eye worm) | LOAG_00794 | leucine Rich Repeat family protein |
Mus musculus | 66385 | protein phosphatase 1, regulatory (inhibitor) subunit 7 |
Neospora caninum | NCLIV_038630 | hypothetical protein, conserved |
Oryza sativa | 4328803 | Os02g0230100 |
Onchocerca volvulus | OVOC9904 | Protein phosphatase 1 regulatory subunit 7 homolog |
Onchocerca volvulus | OVOC9155 | Protein phosphatase 1 regulatory subunit 7 homolog |
Plasmodium berghei | PBANKA_0516600 | leucine-rich repeat protein |
Plasmodium falciparum | PF3D7_1032800 | leucine-rich repeat protein |
Plasmodium knowlesi | PKNH_0617600 | leucine-rich repeat protein |
Plasmodium vivax | PVX_111085 | protein phosphatases PP1 regulatory subunit sds22, putative |
Plasmodium yoelii | PY02599 | protein phosphatase-1 regulatory subunit 7 alpha2 |
Saccharomyces cerevisiae | YKL193C | Sds22p |
Schistosoma japonicum | Sjp_0101350 | ko:K01768 adenylate cyclase [EC4.6.1.1], putative |
Schistosoma japonicum | Sjp_0305390 | Protein phosphatase 1 regulatory subunit 7, putative |
Schistosoma mansoni | Smp_046020 | protein phosphatases pp1 regulatory subunit |
Schmidtea mediterranea | mk4.001831.01 | Protein phosphatase 1 regulatory subunit 7 |
Trypanosoma brucei gambiense | Tbg972.5.620 | protein phosphatase 1, regulatory subunit, putative |
Trypanosoma brucei | Tb927.5.590 | protein phosphatase 1, regulatory subunit, putative |
Trypanosoma congolense | TcIL3000_5_290 | protein phosphatase 1, regulatory subunit, putative |
Trypanosoma cruzi | TcCLB.507867.60 | protein phosphatase 1, regulatory subunit, putative |
Trypanosoma cruzi | TcCLB.510629.420 | protein phosphatase 1, regulatory subunit, putative |
Toxoplasma gondii | TGME49_267550 | leucine-rich repeat protein LRR1 |
Theileria parva | TP04_0289 | hypothetical protein |
Trichomonas vaginalis | TVAG_356270 | leucine-rich transmembrane proteins, putative |
Trichomonas vaginalis | TVAG_216330 | leucine-rich transmembrane protein, putative |
Trichomonas vaginalis | TVAG_427540 | leucine-rich transmembrane protein, putative |
Trichomonas vaginalis | TVAG_039930 | leucine-rich transmembrane protein, putative |
Trichomonas vaginalis | TVAG_268950 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.5.590 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.5.590 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.5.590 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.5.590 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T09A5.9 | Caenorhabditis elegans | embryonic lethal | wormbase |
YKL193C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0516600 | Plasmodium berghei | Dispensable | plasmo |
TGME49_267550 | Toxoplasma gondii | Probably essential | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3